Clinical trials: Hemodialytic Patients
Infection, Hemodialysis Patients
The Impact of Pharmaceutical Care on the Infection Control Measures Among Hemodialytic Patients
The study aims to assess the effectiveness of pharmaceutical care in reducing infection rates among hemodialysis patients with central venous (CV) lines.
- Trial name
- NCT06968754
- Testing
- Intervention Group
- Where
- Iraq
- Volunteers
- 90 people
- Sponsor
- University of Sulaimani
Hemodialytic Patients
Effect of Exercises on Hemodialysis
o Sixty-nine adult patients from both sexes. They were suffering from ESRD on maintenance hemodialysis, their age ranged from50-60 years old were selected from hemodialysis unit at Itay El Baroud central hospital.
- Trial name
- NCT07319468
- Testing
- Aerobic exercises, Open kinetic chain active free range of motion, No intervention
- Volunteers
- 69 people
- Sponsor
- Cairo University
Kidney Diseases
Intra Hemodialytic Oral Protein and Exercise (IHOPE)
Chronic kidney disease (CKD) patients receiving hemodialysis treatment (CKD stage 5) suffer from a variety of co-morbid diseases, many of which may be mechanistically linked.
- Trial name
- IHOPE (NCT01234441)
- Testing
- Control, Protein, Protein + Exercise
- Where
- 2 sites in United States
- Volunteers
- 138 people
- Sponsor
- University of Illinois at Urbana-Champaign
Cardiovascular Disease, Chronic Kidney Disease Patients
A Study Using L5 as a Risk Factor of Cardiovascular (CV) Disease in Chronic Renal and Dialytic Patients
The purpose of this study is to determine whether L5, one of the Low Density Lipoproteins, is an effective predicting factor for cardiovascular disease in chronic renal and hemodialytic patients.
- Conditions
- Cardiovascular Disease, Chronic Kidney Disease Patients, Hemodialytic Patients, High LDL Level
- Trial name
- L5 (NCT01236820)
- Where
- Taiwan
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- China Medical University Hospital
Hemodialytic Patients
Implementation of a Health Action Process Approach-Based Program for People on Hemodialysis Treatment
The aim of the study is to determine the effect of the Health Action Process Approach (HAPA) based program on the treatment compliance and quality of life of people undergoing hemodialysis treatment.
- Trial name
- NCT06723912
- Testing
- Health Action Process Approach-Based Program
- Where
- Turkey (Türkiye)
- Volunteers
- 64 people
- Sponsor
- TC Erciyes University